Liver cancer, particularly hepatocellular carcinoma (HCC), has ... The UCI records an estimated 170 to 200 new cases annually, with aflatoxin exposure accounting for a significant portion.

Although chronic infection with hepatitis B virus and/or hepatitis C virus are the most important risk factors for hepatocellular carcinoma ... to avoid exposure to aflatoxin and other food ...

Prevalence and risk factors Hepatocellular carcinoma (HCC), the most common ... from to prevent the development of fatty liver. > Aflatoxin exposure: Aflatoxins, found in mould-­contaminated ...

Hepatocellular carcinoma is the most common form of primary ... Environmental Factors: Being exposed to certain kinds of toxins and aflatoxins (found in mouldy grains) can also raise the cancer ...

The lifetime risk of hepatocellular carcinoma (HCC) in individuals with LCr is ∼30% ... and/or non-cirrhotic fibrosis (n=44), or aflatoxin exposure (n=10), or from healthy screening populations (n=532 ...

Solute carrier family 25 member 19 (SLC25A19) is a transporter protein of thiamine pyrophosphate across cellular membranes, which is needed as a cofactor for multiple metabolic enzymes and is ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given the increased risk of death from cirrhosis-related complications in patients ...

Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.

The FDA has granted full approval to Bristol Myers Squibb’s (BMS) dual immunotherapy regimen of Opdivo (nivolumab) plus Yervoy (ipilimumab) for adults with unresectable or metastatic hepatocellular ...